palmidrol and dinoprostone

palmidrol has been researched along with dinoprostone in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bisogno, T; De Petrocellis, L; Di Marzo, V; Maurelli, S1
Duarte, ID; Romero, TR1
Duarte, ID; Pacheco, Dda F; Romero, TR1
Duarte, ID; Guzzo, LS; Resende, LC; Romero, TR1
Capoccia, E; Cuomo, R; Esposito, G; Lu, J; Palumbo, I; Sarnelli, G; Steardo, A; Steardo, L; Turco, F1
Cordaro, M; Cuzzocrea, S; Di Paola, R; Esposito, E; Fusco, R; Gugliandolo, E; Impellizzeri, D; Inferrera, A; Siracusa, R1

Other Studies

6 other study(ies) available for palmidrol and dinoprostone

ArticleYear
The endogenous cannabimimetic eicosanoid, anandamide, induces arachidonate release in J774 mouse macrophages.
    Advances in experimental medicine and biology, 1997, Volume: 407

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Amides; Animals; Arachidonic Acid; Arachidonic Acids; Cyclic AMP; Dinoprostone; Endocannabinoids; Enzyme Activation; Ethanolamines; Genistein; GTP-Binding Proteins; Linoleic Acids; Macrophages; Mice; Naphthalenes; Neuroblastoma; Nitriles; Palmitic Acids; Phospholipases A; Polyunsaturated Alkamides; Second Messenger Systems; Staurosporine; Tumor Cells, Cultured; Tyrphostins; Virulence Factors, Bordetella

1997
N-palmitoyl-ethanolamine (PEA) induces peripheral antinociceptive effect by ATP-sensitive K+-channel activation.
    Journal of pharmacological sciences, 2012, Volume: 118, Issue:2

    Topics: Amides; Analgesics; Animals; Dequalinium; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Endocannabinoids; Ethanolamines; Glyburide; Hyperalgesia; Indoles; KATP Channels; Male; Palmitic Acids; Rats; Rats, Wistar

2012
Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.
    Life sciences, 2013, May-02, Volume: 92, Issue:14-16

    Topics: Amides; Analysis of Variance; Animals; Arachidonic Acids; Calcium Channel Blockers; Cannabinoid Receptor Agonists; Chloride Channels; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Endocannabinoids; Ethanolamines; Hyperalgesia; Indoles; Male; Niflumic Acid; Palmitic Acids; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2

2013
CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
    Anesthesia and analgesia, 2013, Volume: 116, Issue:2

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Amides; Analgesics; Animals; Arachidonic Acids; Cannabinoid Receptor Agonists; Dinoprostone; Endocannabinoids; Ethanolamines; Male; Morpholines; Norepinephrine; Pain Measurement; Palmitic Acids; Peripheral Nerves; Polyunsaturated Alkamides; Prazosin; Propranolol; Rats; Rats, Wistar; Reboxetine; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Sympathetic Nervous System; Yohimbine

2013
Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation.
    Gut, 2014, Volume: 63, Issue:8

    Topics: Amides; Anilides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Colitis; Colitis, Ulcerative; Colon, Sigmoid; Cyclooxygenase 2; Dextran Sulfate; Dinoprostone; Endocannabinoids; Ethanolamines; Female; Glial Fibrillary Acidic Protein; Humans; Indoles; Male; Mice; Middle Aged; Nerve Tissue Proteins; Neuroglia; Neutrophil Infiltration; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Palmitic Acids; PPAR alpha; PPAR gamma; Rectum; S100 Calcium Binding Protein beta Subunit; Severity of Illness Index; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha

2014
Effects of a co-micronized composite containing palmitoylethanolamide and polydatin in an experimental model of benign prostatic hyperplasia.
    Toxicology and applied pharmacology, 2017, 08-15, Volume: 329

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Amides; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Dihydrotestosterone; Dinoprostone; Disease Models, Animal; Drug Combinations; Drug Compounding; Ethanolamines; Glucosides; Inflammation Mediators; Male; Oxidative Stress; Palmitic Acids; Prostate; Prostatic Hyperplasia; Rats, Sprague-Dawley; Signal Transduction; Stilbenes; Testosterone Propionate

2017